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Glomerular size-selectivity and microalbuminuria in early diabetic
glomerular disease. Sieving coefficients of uncharged dextrans of graded
size (radii 30 to 60 A) were used to characterize barrier size-selectivity
in nonazotemic diabetic humans with microalbuminuria (Group I, N =
11) or macroalbuminuria (Group 2, N = 21). Compared to a non-
diabetic control group (N 21) the low radius end of the sieving profile
was depressed, whereas the high radius end was elevated in each
diabetic group, more so in Group 2 than Group 1. A heteroporous
membrane model revealed the major portion of the glomerular barrier to
be perforated by restrictive pores of —56 A radius in all three groups.
However, in keeping with a parallel trend for GFR, the relative density
of restrictive pores was control > Group 1 > Group 2. The remaining
minor portion of the barrier was perforated by large, shunt-like pores,
the relative prominence of which ranked Group 2 > Group I > control.
Although the hypothetical, fractional clearance of macromolecules
attributable to the shunt-like pores varied directly with fractional
clearances of albumin and IgG, the progressive increment in the latter
fractional protein clearances in the two diabetic groups was dispropor-
tionate. This raises the possibility that factors in addition to barrier size
defects contribute to the development, magnitude and composition of
proteinuria early in the course of diabetic glomerular disease. Such
factors could include: (I) a progressive decrement in fractional reab-
sorption as the filtered protein load increases, and (2) a concomitant
loss of barrier charge-selectivity, permitting albumin but not IgG to
escape through restrictive pores, and thereby accounting for an ob-
served excess of albumin over IgG clearance in both micro- and
macroalbuminuric stages of diabetic glomerular disease.
The sclerosing glomerular injury that complicates diabetes
mellitus becomes clinically manifest by the development of
proteinuria. By the time proteinuria is detectable by dipstick,
the urinary excretion rate of albumin is usually in excess of 300
j.gImin, a value 10 times higher than the upper limit of normal
[1]. We and others have shown that proteinuria of this magni-
tude is accompanied by abnormal sieving behavior of glomeruli
towards uncharged dextrans of broad size distribution [2—6].
The abnormality is characterized by enhanced filtration of large
nearly impermeant dextran macromolecules, whereas filtration
of dextrans of smaller molecular radius (r) is restricted. The
selective enhancement of transglomerular passage of large
dextrans has been inferred from pore theory to represent the
formation in the glomerular capillary wall of a subset of
enlarged pores [7]. Whereas such enlarged pores are computed
to be few in number, they are estimated to be non-discrimina-
tory towards dextrans of r up to 60 A, and are likely, therefore,
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to be permeable also to albumin (r = 36 A), thereby providing
a possible basis for the phenomenon of albuminuria.
With increasingly widespread use of sensitive immunochem-
ical assays over the past decade, it has become apparent that
subtle elevation of the urinary albumin excretion rate into a
pathological but dipstick negative range (30 to 300 tgImin)
antedates the development of dipstick-positive proteinuria by
several years. This phenomenon, known as microalbuminuria,
is thought to represent the earliest detectable evidence of
functional injury to the filtration barrier in diabetic glonierular
disease (DGD).
It has been suggested that microalbuminuria might reflect a
loss of barrier charge-selectivity as anionic sites in the diabetic
glomerular capillary wall become depleted [81. However, mi-
croalbuminuria has recently been shown to be accompanied by
a parallel increase in the urinary excretion rate of immunoglob-
ulin G (IgG), the second most copious of the plasma proteins
[8]. The large size (r = 55 A) and predominantly neutral or
cationic molecular charge of IgG points to impairment of barrier
size-selectivity, and makes it unlikely that the phenomenon of
microalbuminuria can be explained entirely by an isolated
failure of the glomerular capillary wall to function as a nega-
tively-charged electrostatic barrier [71. We have accordingly
used uncharged dextrans to probe the intrinsic, size-selective
properties of glomeruli in a group of patients with insulin-
dependent diabetes mellitus (IDDM) and microalbuminuria. To
determine whether evolution from an early microalbuminuric to
a subsequent macroalbuminuric stage of DGD is associated
with a graded impairment of barrier size-selectivity, we simul-
taneously studied a second group of overtly proteinuric, but
non-azotemic patients with IDDM.
Methods
Patient population
We recruited for study patients with IDDM, in whom either
dipstick positive proteinuria or a urinary excretion rate of
immunoassayable albumin in excess of 30 p.g/min was detected
for the first time within the preceding 12 months. To ensure that
the recent onset of enhanced albuminuria represented an early
functional expression of diabetic glomerular disease, we in-
cluded only patients in whom the prevailing level of serum
creatinine was within the normal range (<1.4 mg/dl in males,
<1.2 mg/dl in females). The presence of ophthalmoscopic
evidence of diabetic retinopathy was used to make a clinical
diagnosis of DGD. In three instances the diagnosis of diabetic
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retinopathy was equivocal, and the presence of DGD was
confirmed by histopathological demonstration of diffuse dia-
betic glomerulosclerosis in renal tissue obtained by a closed
needle biopsy.
During a five year period (1986 through 1990) 32 patients with
IDDM met the aforementioned functional and diagnostic crite-
ria for early DGD. They were divided into two groups according
to the level of albuminuria at the time of study. Group I
consisted of 11 patients with microalbuminuria, which we have
arbitrarily defined as between 30 and 300 tgImin. The remaining
21 patients had macroalbuminuria (>300 g/min), and they
comprise Group 2. The duration of IDDM in Groups 1 and 2
was 23 2 and 20 2 years (mean SEM) respectively, and the
corresponding daily insulin requirement at the time of study
averaged 44 3 and 44 5 U/day.
Twenty-one healthy volunteers were examined during the
same five year period with identical physiological techniques
and provided a control range for the glomerular functional
qualities of interest. They spanned an age range (18 to 54 vs. 21
to 66 yr) and exhibited a sex distribution (10 males, 11 females)
similar to that encountered in the patient population (15 males,
17 females). They had no history of renal disease, hypertension,
or diabetes. At the time of evaluation each was found to be
normotensive, normoglycemic and to have a negative dipstick
for urinary protein.
Physiological determinations
Each patient and volunteer was studied in a clinical research
center after giving informed consent to a protocol that had been
approved previously by the Institutional Review Board at
Stanford University. Differential solute clearances were per-
formed during water diuresis 21 days after discontinuation of
converting enzyme inhibitor therapy, or between 1 and 7 days
after other antihypertensive agents had been withdrawn in
patients receiving such therapy. The glomerular filtration rate
(GFR) was estimated from the clearance of inulin, renal plasma
flow (RPF) from the clearance of para-aminohippuric acid and
plasma oncotic pressure (IrA) by membrane osmometry, using
methods that have been described in detail elsewhere [2—5].
The fractional clearances (relative to freely permeant inulin)
of endogenous albumin and IgG, and of exogenous uncharged
dextrans of broad size distribution were used to evaluate
glomerular barrier function. Serum and urine were stored at
—70°C for no longer than three months prior to assay. Concen-
trations of albumin and IgG in serum and urine were determined
by radial immunodiffusion. When the concentration of either
protein fell below the detection limits of the low level plates
used for assay of urine (50 and 20 g/ml, respectively), we
employed a sensitive enzyme-linked immunosorbent assay
(ELISA), the lower detection limit of which is only 3 ng/ml [5].
Concentrations of dextran were assayed with anthrone after
plasma and urine had been separated into narrow 2 A fractions
by gel permeation chromatography as described elsewhere [5].
To ensure reproducibility over the five-year study period, the
gel columns were recalibrated at three monthly intervals using
five narrowly dispersed dextran standards of varying but known
molecular radius. The interstudy coefficient of variation (CV)
for dextran sieving coefficients was determined by repeating the
clearance, separation and assay procedures in nine members of
the control group one month after the initial study. The CV was
6.4 for the 30 A fraction and between 2.7 and 3.8% for the
remaining fractions.
Analysis of intrinsic glomerular membrane parameters
The size-selective properties of the glomerular barrier were
computed from dextran sieving profiles using a heteroporous
representation of the glomerular capillary wall that has been
described previously [7]. In this model the major portion of the
capillary wall is assumed to be perforated by restrictive, cylin-
drical pores of identical radius (r0). The model assumes that
there exists in addition a parallel "shunt pathway" which does
not discriminate on the basis of dextran size, and through which
passes a small fraction of the filtrate volume. The shunt
pathway is characterized by a parameter w which governs the
fraction of the total filtrate volume passing through the nonre-
strictive portion of the membrane. According to this model, the
membrane barrier to filtration of water and uncharged macro-
molecules is characterized fully by the values of r0, w, and Kf;
where Kf is the product of the effective hydraulic permeability
and the total glomerular capillary surface area (for two kid-
neys). An additional membrane parameter that can be derived
from K and r0 is the ratio of effective pore area-to-pore length
(S'/l), which is closely related to the apparent number of
restrictive pores in the two kidneys (N). More precisely, N =
S'/irr02. Thus, if I and r0 are nearly constant, changes in S'/l are
very nearly proportional to changes in the total number of
restrictive pores, N [9, 10].
To take the effect of GFR determinants on convective and
diffusive transmembrane transport into account, the model
requires knowledge of GFR, RPF, ITA and the transcapillary
hydraulic pressure difference, P [7, 9]. The latter quantity
cannot be determined directly in humans. However, using an
indirect curve fitting technique, we have estimated that zP
approximates 35 mm Hg in the healthy human kidney, and have
assigned this value to the control group in the present study [11,
12]. Micropuncture determinations in insulin-treated diabetic
rats have revealed moderate hyperglycemia to be associated
with glomerular capillary hypertension and elevation of P [13,
14]. We accordingly assigned two levels of P to the diabetic
groups. A lower level of 35 mm Hg is intended to cover the
possibility that P fails to become elevated in diabetic humans,
while an upper level of 40 mm Fig is intended to simulate the
situation in the diabetic rat.
Statistical analysis
Differences between groups were evaluated by ANOVA and
Duncan's test for multiple comparisons using the CLINFO
system. Univariate linear regression analysis was used to
explore associations between the measured variables. The
distribution of protein excretion rates, fractional protein clear-
ances and membrane parameters (other than r0) was skewed,
and these values were log-transformed before analysis. All
values are presented as the mean I standard error, Intergroup
mean values that do not differ significantly by Duncan's multi-
ple comparison test in Tables 1 to 5 are designated by the same
letters.
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Table 1. Filtration dynamics
Control
Diabetic glomerulopathy
Group I Group 2
GFR ml/min/1.73 m2
RPF mllmin/1.73 m2
Filtration fraction
Afferent oncotic pressure
mm Hg
Mean arterial pressure
mm Hg
108 3
582 24k'
0.19 o.ola
23.0 0,4
85 2
90 iia554 44
0.17 0.03a
23.2 l.oa
96 3"
70602 52
0.10 0.02"
21.4 o.9
103 4b
Table 2. Renal protein handling
Diabetic glomerulopathy
Control Group I Group 2
Excretion rate g/min
Albumin 13 3 140 20 2376 367
IgG 1.7 0.3 17 4b 205 4l
Serum concentration ing/dI
Albumin 3860 91 3871 127 3342 146"
IgG 946 74 1090 98 877 74a
Fractional clearance(x l0)
Albumin 0.35 o.loa 5.8 13b 141 33C
IgG 0.14 0.03a 2.6 0.9" 62 21c
IgU-to-albumin clearance 0.57 0.15k 0.60 0.15a 0.31 0.04
ratio selectivity index
Results
Filtration dynamics
Despite an absence of azotemia, GFR was significantly
depressed by 35% in diabetic Group 2 (Table 1). The RPF
remained within the normal range however, with the result that
the filtration fraction was also markedly depressed. Neither
GFR, RPF nor the filtration fraction in diabetic Group 1 with
microalbuminuria differed from corresponding control values.
Whereas plasma oncotic pressure tended to be slightly de-
pressed in diabetic Group 2 only, the arterial pressure was
significantly elevated in both diabetic groups, exceeding the
control value by 11 in Group 1 and by 18 mm Hg in Group 2, on
average.
Renal protein handling
The incremental albumin excretion rate according to which
the diabetic patients were grouped was accompanied by a
parallel increase in the urinary IgG excretion rate (Table 2).
Urinary losses of albumin in Group 2 but not Group 1 were
sufficiently heavy to lower the level of circulating albumin in
serum. The corresponding serum IgG level was numerically but
not significantly lowered.
The fractional clearances of albumin and IgG varied in
parallel with, but were proportionately more elevated than
corresponding protein excretion rates in the two diabetic groups
(Table 2). The relationship between the fractional clearances of
each protein is illustrated in Figure 1. As shown the fractional
clearance of albumin was highly correlated with that of IgG
Fig. 1. Relationship between the fractional clearances of IgG and
albumin in control and diabetic subjects. Symbols for control and
diabetic categories in this and subsequent figures are: control (•), group
1 (0) and group 2 (. Some control subjects and 2 members of the
diabetic Group I were studied before the ELISA technique for deter-
mining urinary albumin and IgG concentration was available, with the
result that the regression analysis does not include all members of these
2 groups. r = 0.95; P < 0.0001.
over the range of values observed in the control and diabetic
groups; by linear regression analysis the coefficient of correla-
tion was 0.95 (P < 0.0001). Figure 1 also shows that fractional
albumin clearance exceeded that of IgG with only rare excep-
tions. Surprisingly, the proteinuria tended to be most selective
in diabetic Group 2, with the selectivity index (IgG-to-albumin
clearance ratio) averaging only 0.31 0.04 compared to 0.60
0.15 and 0.57 0.15 in diabetic Group 1 and controls, respec-
tively (Table 2).
Trans glomerular dextran transport
Like inulin, dextran fails to undergo either measurable tubu-
lar reabsorption or secretion [10]. It follows that dividing the
clearance of a given dextran by that of inulin corrects for water
reabsorption along the nephron, and thus provides a measure of
the sieving coefficient (Bowman's space-to-plasma concentra-
tion ratio) for that dextran. The sieving coefficients for dextrans
of graded size are summarized in Table 3, and the mean dextran
sieving profiles for each group are illustrated in Figure 2. The
configuration of the sieving profiles in the two diabetic groups
was similarly altered from that in controls. The low radius ends
of the diabetic profiles were significantly depressed. Each
Means in this and subsequent tables that are not different from one
another by Duncan's multiple comparison test are designated with the
same letter.
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Table 3. Fractional dextran clearances
0.001
24 28 32 36 40 44 48 52 56 60
Dextran radius,A
Fig. 2. Fractional dextran clearance profiles in healthy controls (---)
and the two diabetic groups (0, micro; •, macro).
diabetic sieving profile then intersected the corresponding con-
trol profile at between 47 and 48 A. Beyond the intersection the
passage of large, nearly impermeant dextrans was enhanced,
although only the elevation of the sieving coefficients for the
two largest dextran fractions (r = 58 and 60 A) in diabetic
Group 2 reached statistical significance (Table 3). Nevertheless,
the trend to selective elevation of sieving coefficients of large,
nearly impermeant dextrans points to a membrane with a less
sharp cut-off in the diabetic groups than in controls.
Analysis of membrane parameters
The intrinsic membrane properties of the members of each
group were computed by applying the dextran sieving profiles,
GFR, RPF, ITA and the assumed levels of P to the "isoporous
plus shunt" membrane model [7]. The computed range for each
membrane parameter is provided in Table 4. A graded reduction
for Kf and S'/l is evident, such that the magnitude of ultrafil-
tration capacity of all filtering glomerular capillaries in the two
human kidneys is control > diabetic Group 1 > diabetic Group
2. Notice that a 5 mm Hg elevation of zP has a marked effect on
computed K1 and S'/l, lowering these two quantities by between
25 and 40%. Notice also that although the range of computed
values for Kf and S'/l in microalbuminuric diabetic Group 1
does not overlap the estimated control values, depression of
either the ultrafiltration coefficient (K1) or pore density (S'Il)
does not reach significance unless P is elevated to 40 mm Hg
(Table 4). In contrast each measure is significantly depressed
below the corresponding control value in diabetic Group 2,
regardless of whether or not P is elevated.
In contrast to K1 and S'/l, the computed values for the two
pore parameters are only slightly influenced by a 5 mm Hg
increase in zP (Table 4). The radius of restrictive pores (r0) is
below control by approximately I A in each diabetic group. The
opposite is true of o, the parameter governing the non-
discriminatory pores. The shunt pathway, as reflected by (00, is
three to four times more prominent in Group 2 diabetics than in
controls (4.0 to 4.8 vs. 1.3 x l0—). Once again the correspond-
ing value for Group 1 is intermediate (1.6 to 2.3 x l0).
However, as for K1 and S'/l, the excess of a over control only
reaches statistical significance in the event that P is elevated in
these microalbuminuric subjects.
Given that the higher arterial pressure in diabetic subjects is
likely to be transmitted into glomerular capillaries, we will
assume that P = 40 mm Hg in diabetic Groups 1 and 2 in an
attempt to explore further the relationship between proteinuria
and shunt-like pores.
That both the development and magnitude of proteinuria in
DGD is related to the prominence of the shunt pathway is
indicated by a strong relationship between fractional albumin or
IgG clearance and w,, among all subjects studied (Fig. 3). In an
effort to determine whether the shunt pathway can account for
the observed fractional protein clearances, we have computed
the clearance of a hypothetical macromolecule that is attribut-
able to the shunt pathway (Table 5). This quantity is denoted EL
and neglects tubular reabsorption [71. Because the luminal
concentration of a macromolecule will increase with distance
along the glomerular capillaries as water is removed by ultrafil-
tration, 0,. slightly exceeds w. As shown in Figure 4, EL
exceeds the respective fractional clearances of albumin and IgG
in each group, suggesting that transmembrane shunting of
plasma is always sufficient to account for the observed magni-
tude of the fractional protein clearances. We note with interest,
however, that the trend for 0,. in diabetic Group 1 to exceed
control does not reach statistical significance, and that EL is
significantly enhanced only in Group 2 (Table 5). Also notewor-
thy is the disparate relationship between 0,. and the fractional
Control
Diabetic glomerulopathy
Group 1
Group 2
30A 34A 38A 42A 46A SOA 54A 58A
0.7158a 0.4162' 0.2l9P' 0.1077' 0.0485a 0.0210' 0.0089a Ø4Ø
±0.0247 ±0.0115 ±0.0068 ±0.0036 ±0.0020 ±0.0012 ±0.0006 ±0.0004
0•5757b 03338b 01710b 00870b 0.0434' 0.0217a 0.OlOSa 00059a,b
±0.0454 ±0.0197 ±0.0151 ±0.0111 ±0.0079 ±0.0054 ±0.0033 ±0.0022
0.5321" 03001b 01611b 00842b 0.0430k' 0.0225a 0.0124' 00077b
±0.0290 ±0.0145 ±0.0081 ±0.0050 ±0.0031 ±0.0021 ±0.0014 ±0.0011
1
0.1
0.01
(-)C
I-
0)0
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0) I-.
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1)
0)
C0
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0) I-
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Table 4. Membrane parameters
Control
Diabetic glomerulopathy
Group I Group 2
mm Hg
Kml/min mmHgIl.73 m2
S'Il km
r0A
x 10
35
16.2 2.0
349 43a
56.9 0.2
1.3 0.la
35
12.5 2.5a
282 53
55•4 0•6b
1.6 0.3
(40)
(7.4 10b)
(165 22b)
(56.0 Ø,7)a
(2.3 05b)
35
9.0 25b
214 65b
55.6 O.5t
4.0 07b
(40)
(5.1 0.7)
(114 IT)
(56.0 0.4a)
(4.8 0.8c)
See Table I legend for description of data presentation.
io io 102 10_hlO_4 io3
Shunt parameter, COO
Table 5. Hypothetical fractional clearance (via shunt) and
reabsorption
Control Group I Group 2
e x 1O 416 42 544 166k 769 108b
o aIb/O 0.0009 0.0003a 0.016 0.004b 0.22 0.06c
o IgG/O. 0.0004 o.0ool 0.009 0003b 0.10 0.04c
See Table 1 legend for description of data presentation.
protein clearances. Whereas exceeds the respective frac-
tional clearances of albumin and IgG by five- and tenfold in
diabetic Group 2, the corresponding excess in diabetic Group 1
and controls is by 2 and 3 orders of magnitude respectively (Table
5, Fig. 4). This suggests that factors other than or additional to
transmembrane shunting of albumin and IgG may be implicated in
the differences in the magnitude of proteinuria between patients
with microalbumjnurja and those with macroalbuminuria.
Discussion
Although cross sectional in nature, our theoretical analysis of
membrane pore structure suggests that evolution of DGD
through a microalbuminuric stage to one of overt proteinuria
represents a continuum of progressively deranged glomerular
capillary wall function. This derangement is characterized by a
progressive reduction in the number of glomerular pores (j S'/l)
accompanied by a shift in pore-size distribution towards pores
Fig. 3. Relationship between the fractional
urinary clearances of albumin (A) and IgG
(B), and the corresponding shunt parameter
(w0) in control (•) and diabetic subjects (0,
micro; •, macro), assuming an elevated tP
of 40 mm Hg in the diabetic subjects. The
regression equations are y = 1.97 + 2.29 x
and y = 2.02 + 2.48 x for albumin and IgG,
respectively. If P remains 35 mm Hg in the
diabetic subjects, the regression equations and
correlation coefficients are y = 1.95 + 2.22 x,
_______
r = 0.66, and y = 1.80 + 2.32 x, r = 0.70, for
— 1
albumin and LgG, respectively. The10 explanation for the reduced number of control
and Group I comparisons is given in the
legend to Figure 1.
of larger radius (' w0), A progressive reduction in pore number
likely provides the basis for the irrevocable decline in GFR that
typifies DOD, and is consistent with morphometric analyses of
glomerular structure, which suggest an incremental lowering of
glomerular capillary filtration surface area as DGD advances
[15, 16j. Although its structural basis is unknown, the growing
fraction of glomerular pores which behave as shunts could
provide a basis for increasing proteinuria as DGD progresses
from the micro- to the macroalbuminuric stage of injury. In
keeping with this possibility we have shown a strong correlation
between the magnitude of the shunted fraction of filtrate volume
(w0) and that of fractional clearances of albumin and IgG in the
subjects of the present study (Fig. 3). That transmembrane
shunting accounts exclusively for the magnitude and composi-
tion of proteinuria in early DOD cannot be inferred from the
present findings, however.
One of the findings that casts doubt upon shunt-like, barrier
defects as an exclusive mechanism for proteinuria is the excess
of albumin over IgG clearance over the entire range of barrier
dysfunction observed in the present study. Were pores that fail
to restrict dextrans of r = 60 A also nondiscriminating towards
albumin and IgG, and the sole portal of entry for each protein
into Bowman's Space fluid, one would expect equality of the
respective fractional protein clearances. On the other hand, the
enhancement of albumin over IgG clearances could be ex-
plained by a dual route of transcapillary albumin escape. Judged
10—i
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io
106
U,
C)C
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CD
U)
C)
C
a)1-'0
a
CDC0
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CD
U-
A Albumin
a
••
• U
U. U UI-aa
.
U
— •.p.
000 0
0
—
• 00
• •
•• •, •
••• r=0.72
P< 0.0001
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0•0 U
•00
— 000U
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r = 0.77
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Fig. 4. Fractional clearance attributable to the shunt pathway (@j in
each group (assuming LP is 40 mm Hg in the diabetic groups), and the
corresponding fractional urinary clearances of albumin (A) and IgG(G). 'P < 0.05 vs. control; tP < 0.05 vs. group I.
by its molecular radius, it is conceivable that albumin (r, = 36
A) can permeate the restrictive pores of the major component of
the membrane (r0 = 56 A), whereas IgG (r = 55 A) cannot.
Thus, loss of fixed, negatively-charged sites from the restrictive
portion of the membrane in DGD could impair electrostatic
retardation, and in this way provide a second pathway for
albumin filtration which is inaccessible to IgG [17]. Yet another
explanation for disproportionate clearance of albumin is that
the predominantly neutral or cationic molecules of filtered IgG
bind more avidly to the negatively-charged glycocalyx of prox-
imal tubular brush border than do the anionic molecules of
filtered albumin [18, 19]. Facilitated endocytosis of IgG by
proximal tubular cells could then permit a disproportionate
fraction of the filtered albumin load to reach final urine.
That proteinuria in DGD may not be uniquely attributable to
shunt-like glomerular pores in DGD is also suggested by our
computations for O, the fractional clearance of any large,
non-reabsorbed molecule, which can be ascribed to the postu-
lated shunts. As noted already in connection with Figure 4, the
graded increases above control in fractional protein clearance
of diabetic Groups 1 and 2 are proportionately much larger than
the calculated increases in O. Stated another way the values of
®,. suggest that normal individuals and diabetic patients with
microalbuminuria should be almost as heavily proteinuric as the
macroalbuminuric diabetic patients of Group 2, yet of course
they are not.
Tubular reabsorption of a variable fraction of filtered protein
among the groups may contribute to but does not appear to
account completely for the discrepancy, however. Fractional
protein reabsorption increases as the filtered load diminishes
[20, 21]. In keeping with the observed disparity in the three
study groups, this should lower the urinary fractional clearance
of proteins by the greatest percentage in controls, by an
intermediate percentage in diabetic Group 1, and by the small-
est percentage in diabetic Group 2. However, dividing frac-
tional protein clearances by €L suggests that 99% or more of the
shunted protein load would have to be reabsorbed in controls
and patients of diabetic Group 1, if this were the sole factor
(Table 5). Such fractional reabsorptive rates are greatly in
excess of corresponding rates determined directly by micro-
puncture in non-proteinuric rats [20, 21]. To the extent that
fractional protein reabsorption in the human subjects of the
present study resembles that in the rat, we infer that the
corresponding fractional reabsorption of protein would be no
greater than 90% in the members of the control group and those
of diabetic Group 1.
An attractive explanation for the remaining discrepancy
between O. and fractional protein clearances relates to the fact
that random-coil polymers such as dextran do not behave as the
ideal, neutral spheres assumed in the pore size calculations.
This has been demonstrated both in vitro by diffusion experi-
ments using synthetic membranes of uniform and independently
measured pore size [22, 23] and in vivo in the rat glomerulus
[24, 25]. In both circumstances the transmembrane passage of
uncharged dextrans has been shown to be more rapid than that
of uncharged, spherical molecules (ficolls or proteins) of equiv-
alent Stokes-Einstein radius. Thus, applying the conventional
solid-sphere model to dextran data will tend to overestimate the
membrane permeability to proteins. In particular much or all of
the transport of the largest dextrans in controls, which the
present model attributes to the shunt, may in fact represent the
unusually rapid passage of dextrans through a small-pore com-
ponent of the membrane, one which permits little or no passage
of albumin or IgG. According to this reasoning the values of O,.
in all groups might be overestimated by roughly similar
amounts. It follows that the actual value of in the two
diabetic groups could be smaller than those estimated in Table
5 and perhaps, sufficient only to account for the observed
fractional clearance of IgG, but not that of albumin.
A more quantitative test of this hypothesis must await the
development of more realistic models for hindered transport of
random-coil polymers. If confirmed, however, it would point
away from shunt-like pores as a sole explanation for micro- or
macroalbuminuria in early DGD. A concomitant increase in
albumin passage through restrictive pores which are charge-
depleted could then be invoked to explain the predominance of
urinary albumin over IgG clearance in this disorder.
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